Synaptic recruitment of AMPA receptors (AMPARs) represents a key postsynaptic mechanism driving functional development and maturation of glutamatergic synapses. At immature hippocampal synapses, PKA-driven synaptic insertion of GluA4 is the predominant mechanism for synaptic reinforcement. However, the physiological significance and molecular determinants of this developmentally restricted form of plasticity are not known. Here we show that PKA activation leads to insertion of GluA4 to synaptic sites with initially weak or silent AMPAR-mediated transmission. This effect depends on a novel mechanism involving the extreme C-terminal end of GluA4, which interacts with the membrane proximal region of the C-terminal domain to control GluA4 trafficking. In the absence of GluA4, strengthening of AMPAR-mediated transmission during postnatal development was significantly delayed. These data suggest that the GluA4-mediated activation of silent synapses is a critical mechanism facilitating the functional maturation of glutamatergic circuitry during the critical period of experience-dependent finetuning.
Introduction
GluA4 AMPAR subunit is transiently expressed in hippocampal pyramidal neurons during the first postnatal week, which corresponds to the time of activity-dependent fine-tuning of glutamatergic synaptic connectivity. This involves strengthening and stabilization of immature synapses via both presynaptic and postsynaptic mechanisms. The regulated insertion of AMPA receptors to weak or functionally silent synapses is thought to be a key postsynaptic mechanism underlying experience-dependent maturation of transmission (Kerchner and Nicoll, 2008; Hanse et al., 2013) .
A suggested model for activity-dependent synaptic recruitment of AMPARs involves insertion of receptors to extrasynaptic areas followed by lateral diffusion to synaptic sites and capture within the postsynaptic density (PSD) (Opazo and Choquet, 2011) . However, early in development, spines, which would limit lateral diffusion, are mostly absent (Fiala et al., 1998) and the molecular composition of the postsynaptic density (PSD) is distinct from the adult (Elias et al., 2006; Bassani et al., 2013) . Consequently, the detailed molecular mechanisms underlying AMPAR and, in particular, GluA4 trafficking at immature synapses are not completely understood. Similar to other types of ionotropic glutamate receptors, synaptic recruitment of GluA4-containing AMPARs is regulated by interactions mediated by its C-terminal domain (CTD; Zhu et al., 2000; Boehm et al., 2006; Luchkina et al., 2014) , which is a target for phosphorylation by PKA (Carvalho et al., 1999; Esteban et al., 2003) . At GluA4 expressing developing synapses, PKA activation is both necessary and sufficient to drive AMPA receptors to synapses and to produce long-term potentiation (LTP) of synaptic transmission (Zhu et al., 2000; Esteban et al., 2003; Yasuda et al., 2003; Luchkina et al., 2014) . This form of plasticity is restricted to early development (the first postnatal week in rodents), after which LTP becomes dependent on multiple kinases and, in particular, Ca 2þ /calmodulin dependent kinase II (CaMKII; e.g. Yasuda et al., 2003) . Here we have examined the molecular mechanism and physiological significance of the immature type GluA4-PKA dependent LTP.
Materials and methods

Animals
Experiments were performed on 4-to 6-day-old Wistar rats and 4-to 34-day-old wild-type (WT) or GluA4À/À mice kindly provided by Hannah Monyer (University of Heidelberg, Heidelberg, Germany; Fuchs et al., 2007) . All experiments were done in accordance with the University of Helsinki Animal Welfare Guidelines.
Slice preparation
Animals were rapidly decapitated, and the brains were quickly removed from the skull and submerged in ice-cold dissection solution containing 124 NaCl, 3 KCl, 1.25 NaH 2 PO 4 , 10 MgSO 4 , 26 NaHCO 3 , 15 D-glucose, and 1 CaCl 2 and equilibrated with carboxygen (5% CO 2 þ 95% O 2 ). Parasagittal hippocampal slices (350e400 mm) were cut with a vibratome (Leica Microsystems, Wetzlar, Germany) in dissection solution and placed in a recovery chamber, submerged in solution containing the following (mM): 124 NaCl, 3 KCl, 1.25 NaH 2 PO 4 , 3 MgSO 4 , 26 NaHCO 3 , 15 D-glucose, and 2 CaCl 2 (bubbled with carboxygen). To prevent recurrent excitation, the CA3 region was cut away in experiments where evoked EPSCs were recorded.
Electrophysiology
After 1e5 hour storage in a recovery chamber, an individual slice was transferred to a recording chamber where it was constantly perfused with oxygenated ACSF containing (mM): 124 NaCl, 3 KCl, 1.25 NaH 2 PO 4 , 1 MgSO 4 , 26 NaHCO 3 , 15 D-glucose, and 2 CaCl 2 (at 30 C). Electrophysiological experiments were performed on CA1 pyramidal cells under visual guidance using a MultiClamp 700A amplifier (Molecular Devices, Sunnyvale, CA, USA) in whole-cell voltage-clamp mode. The electrodes were 3e5 MU and contained the following (mM): 130 CsMeSO 4 , 10 HEPES, 0.5 EGTA, 4 Mg-ATP, 0.3 Na-GTP, 5 QX-314, and 8 NaCl (278 ± 5 mOsm, pH 7.2e7.4). Uncompensated series resistance (<30 MU) was monitored throughout experiments, and recordings were interrupted if it changed by >20%. Evoked EPSCs were elicited by Schaffer collateral pathway stimulation with a bipolar electrode in the presence of GABA A -receptor antagonist picrotoxin (100 mM). For mEPSCs recordings, 1 mM TTX was also included. Baseline stimulation frequency was 1/20 s or 1/15 s and the intensity was adjusted to the minimum strength eliciting a stable response and, for experiments estimating AMPA/NMDA ratio, with an average amplitude in the range 20e50 pA at À70 mV. To activate only a few presynaptic fibers, a minimal stimulation protocol was employed. The stimulus intensity was set so that a 25% change did not affect response amplitude or failure rate and failures were observed in about 50% of the time (Stevens and Wang, 1995; Isaac et al., 1996) . Pharmacological compounds were obtained from Tocris Bioscience (Bristol, UK) and Abcam (Cambridge, UK). Forskolin was applied in <15 min after obtaining whole cell access.
The relevant purified GST-fusion proteins or GST were prepared as described (Coleman et al., 2010) . Aliquots of all the protein constructs were run on gel and stained with Coomassie Blue to confirm the correct size and integrity of the protein. The proteins were dialysed against a buffer containing (mM): 130 CsMeSO 4 , 10 HEPES, 0.5 EGTA and 8 NaCl (pH 7.2e7.4) and included in the intracellular solution at a concentration of 0.5 mM. Interleaved control experiments with GST and/or an effective GST-A4 CTD construct were done to control intracellular dialysis and peptide diffusion into the recorded cell. Encoded residues were GluA4(835e902) for complete GluA4 CTD (based on numbering of the full polypeptide sequence, UniProt P19493). The GluA4 CTD mutations encoded the residues; GluA4(870e902), GluA4(835e869), GluA4(835e901), GluA4(835-896), GluA4(835e901; L901A), GluA4(835e902; S862A), GluA4(835e902; S862D), GluA4(835e902; R841S, K845S, R846S). Mutations were generated by PCR and standard molecular biological techniques and were verified by sequencing.
WinLTP 2.01 program (Bristol, UK; Anderson and Collingridge, 2001 ) was used for data acquisition. Spontaneous events were detected using the Mini Analysis Program 6.0.7. (Synaptosoft, Decatur, GA, USA). The amplitude threshold was set to 4e5 times of the baseline RMS (root mean square) noise level and the all detected events were verified visually. Evoked synaptic responses were analyzed using WinLTP. The amplitude of AMPA currents at À70 mV was measured as the peak relative to the average baseline level before stimulation, for NMDA currents at þ40 mV 50e60 ms after stimulation. Decay time of the AMPA currents was calculated from 90 to 37% of the peak amplitude using the Mini Analysis Program 6.0.7. In experiments, where minimal stimulation was used, the amplitude threshold for identification of responses vs. failures at both À70 and þ 40 mV was set to 2 times of the RMS noise level at þ40 mV due to the higher noise level at this potential, all responses were verified visually and were invariant in shape. For time course plots, detected events were calculated in 60 s or 120 s bins and normalized to the baseline level. For the histograms, data are presented as percentage of last 10 min of the relevant dataset after drug application relative to the baseline level.
Cell culture, DNA constructs and transfection
Primary hippocampal neurons were obtained from E17 mouse embryos treated with papain (500 mg/ml) and mechanically triturated to produce a single cell suspension. Cells were plated at a density of 50 000 cells/cm 2 on poly-D-lysine-coated : 12 mm round glass coverslips in 24-well plates in glial cell-conditioned B27-supplemented Neurobasal medium (Life Technologies, Carlsbad, CA, USA). The cells were transfected on day 10 in vitro (DIV10) by using calcium phosphate method (Li et al., 2007) . The medium was changed to pre-warmed Neurobasal (no supplements) containing 10 mM MgCl 2 (transfection medium) 1 h before transfection. For each well, a total of 35 ml contained: 2 mg plasmid DNA, 0.25 M CaCl 2 mixed with 17.5 ml of 2xHEPES-buffered saline (pH 7.06; 42 mM HEPES, 274 mM NaCl, 10 mM KCl, 1.4 mM Na 2 HPO 4 , 15 mM D-glucose); transfection mixture was added dropwise to cells. Cells were incubated at 37 C in 5% CO 2 for 4 hours. After a fine precipitation formed, cells were washed with transfection medium 2e3 times. Thereafter, it was replaced with the original glialconditioned culture medium. The cells were analyzed 5e7 days later (DIV 15e17). Constructs used for transfection were based on the N-terminally eGFP-tagged rat GluA4 (UniProt P19493; flip isoform) where fulllength construct encoded residues 22e902 (residues 1e21 encode a signal peptide). The encoded residues in GFP-GluA4 mutants were: GFP-A4(22e896), GFP-A4(22e837, 870e902), GFP-A4(22e902; R841S, K845S, R846S). Mutations were generated by PCR and standard molecular biological techniques. All constructs and mutations were verified by sequencing the entire PCR amplified region.
Immunofluorescence staining and confocal microscopy
For surface immunostaining of GFP constructs, anti-GFP antibodies (1:1000, Abcam, Cambridge, UK) were added into each well and incubated for 30 min at room temperature. Then hippocampal neurons were washed in PBS (2 Â 10 min) and fixed in 4% paraformaldehyde in PBS for 20 min, rinsed with PBS (2 Â 10 min), and permeabilized in 0.2% Triton-X-100 in PBS for 10 min. The cells were then incubated for 2 h with 4% bovine serum albumin (BSA), 3% normal goat serum (NGS), 0.05% gelatin and 0.2% Triton X-100 (blocking solution; in PBS) and left overnight at þ4 C with the primary antibodies/antisera in the blocking solution. For colocalisation studies, anti-PSD95 monoclonal antibody (1:1000; 75-028, NeuroMab, Davis, CA, USA) was used. In some cases anti-MAP2 mouse monoclonal antibodies (1:500, Sigma-Aldrich, St. Louis, MO, USA) were used as a dendritic marker. The stained cells were washed with 0.2% Triton X-100/PBS (1 Â 10 min) and with PBS/1%BSA/1%NGS (2 Â 10 min) and incubated with appropriate Alexa Fluor 405 (blue)-and Alexa Fluor 568 (red)-conjugated secondary antibodies (1:500, Life Technologies, Carlsbad, CA, USA). After cells were mounted in Fluoromount™ Aqueous Mounting Medium (Sigma-Aldrich, St. Louis, MO, USA), images were acquired as z stacks using the Â63 objective 0.7 Â mechanical zoom at optimal resolution in Zeiss LSM 710 confocal microscope.
Image analysis
Images were collapsed to maximal projection and analyzed in Matlab with SynD (Schmitz et al., 2011) . Background fluorescence was measured in a region without cells and subtracted prior to analysis in ImageJ (Schneider et al., 2012) . Synapses were detected based on the staining for PSD95. Detected regions were subsequently used to measure the synaptic intensity of GFP-A4 constructs. Mean fluorescent intensity of the soma was calculated by averaging the intensity from 10 regions of interest (ROIs) placed in the soma. Synaptic recruitment was estimated as the ratio of the mean intensity at synapses to mean somatic intensity, while dendritic delivery e as mean dendritic intensity (including synaptic and extrasynaptic regions) to mean somatic intensity.
Statistical analysis
All the error bars represent the standard error of the mean (SEM). Statistical significance has been assessed using ANOVA or Student's two tailed t-test in SigmaPlot 11 (Systat Software, San Jose, CA, USA) or IBM SPSS Statistics (IBM Corporation, North Castle, NY, USA). If the assumption of normal distribution of the residuals failed, random permutation tests for ANOVA were performed in R software (R Core Team, 2014) . The age-dependence of AMPA/NMDA ratio was tested using simple linear regression analysis (method of least squares). p < 0.05 was considered as statistically significant.
Results
PKA activation leads to synaptic unsilencing via insertion of GluA4
We recently showed that forskolin application leads to an increase in both the amplitude and frequency of miniature EPSCs (mEPSCs) at immature CA1 pyramidal neurons, due to PKAdependent mobilization of GluA4 (Luchkina et al., 2014) . The observed increase in mEPSC frequency suggests activation of postsynaptically silent synapses via insertion of GluA4. To characterize this effect in more detail, we used minimal stimulation to record inputs with an initially low success rate (<0.5) of AMPARmediated EPSCs in the neonatal (P4-P8) CA1 pyramidal neurons in both wild type (WT) and GluA4À/À mice (Fuchs et al., 2007) . The AMPAR-mediated component of the EPSC was recorded at a holding potential of À70 mV in the presence of picrotoxin (PiTX) to block fast GABAergic inhibition, while the NMDAR-mediated component was recorded at þ40 mV and isolated based on its slow kinetics. In 6 out of 9 WT cells, the success rate of AMPARmediated EPSCs was significantly lower as compared to NMDA (0.18 ± 0.03 for AMPA, 0.40 ± 0.09 for NMDA; n ¼ 6; p < 0.01), indicative of postsynaptically silent synapses. Interestingly, no significant difference between AMPA and NMDA success rates were detected in any of the recorded cells in GluA4 À/À mice (n ¼ 9), suggesting that lack of GluA4 affected the proportion of silent inputs in the synapse population. Furthermore, the basal potency of AMPAR mediated EPSCs but not NMDAR-mediated EPSCs were higher in GluA4À/À as compared to WT (p < 0.05; Fig. 1B vs Fig. 1A ), while no statistically significant difference in the AMPA or NMDA success rate was detected between the genotypes.
In the WT mice, extracellular application of forskolin (50 mM) led to a significant increase in the amplitude of AMPA-receptor mediated EPSCs, due to an increase in both potency (192 ± 29%, n ¼ 9, p < 0.05) and success rate (265 ± 54%, n ¼ 9, p < 0.01; Fig. 1A) . A single example of a synapse showing weak or subthreshold AMPA receptor mediated transmission but a visible NMDA-receptor mediated EPSC under basal conditions, and robust upregulation of AMPA currents upon forskolin application is depicted in Fig. 1A (top panel). No changes in the NMDAR-mediated transmission in response to forskolin application were detected (potency: 98 ± 10%, p ¼ 0.73; success rate: 109 ± 17%, p ¼ 0.89; Fig. 1 ), suggesting that presynaptic efficacy was not significantly altered and further, that the potentiation of EPSCs was most likely driven by postsynaptic insertion of AMPA receptors. In contrast, forskolin had no effect on the potency of AMPA and NMDA EPSCs in the GluA4À/À mice (99 ± 13% and 104 ± 17%, respectively). A small non-significant increase in the success rate of both AMPA and NMDA EPSCs was observed, presumably mediated by some compensatory presynaptic mechanism (AMPA: 148 ± 36%; NMDA: 195 ± 75%, p ¼ 0.39; Fig. 1B ).
These data together with our previous results (Luchkina et al., 2014) show that PKA activation leads to insertion of GluA4 to immature synapses with initially weak or silent AMPA transmission.
Maturation of AMPAR-mediated transmission is perturbed in the absence of GluA4
During the first two weeks of development, the relative contribution of AMPARs to postsynaptic currents increases (Crair and Malenka, 1995; Durand et al., 1996; Hsia et al., 1998; Lu et al., 2001; Ye et al., 2005) . To study the role of GluA4 in the AMPAfication of the glutamatergic synapses, we analyzed the amplitude ratio of the AMPAR-vs. NMDAR-mediated EPSCs in WT and GluA4À/ À mice at different developmental stages ( Fig. 2A) . A significant correlation of AMPA/NMDA ratio with age during first two weeks of development was observed in WT mice (linear regression analysis: r 2 ¼ 0.34 for P4 to P15, p < 0.001, n ¼ 41), but not in GluA4À/À mice
n ¼ 19) and at P14-15 (WT n ¼ 9, GluA4 À/À n ¼ 11), the AMPA/ NMDA ratio was significantly smaller in the GluA4 À/À mice as compared to the WTs (p < 0.05; Fig. 2B ). In GluA4À/À mice, a steep increase in AMPA/NMDA ratio was observed between P14 and P18 ( Fig. 2A, B) , a developmental stage when the ratio was already stabilized to apparent adult levels in the WT mice. Finally, no significant differences in the AMPA/NMDA ratio between the genotypes were detected at P16-P34.
Homomeric GluA4 AMPA receptors and in particular, the GluA4 'flop' splice variants show faster kinetics as compared to other types of AMPARs (Mosbacher et al., 1994; Geiger et al., 1995; Zhu, 2009) , which may affect the amount of depolarization at postsynaptic neurons in response to receptor activation. The decay time of AMPA EPSCs increased during development in both WT and Fig. 1 . PKA activation leads to insertion of GluA4 to immature synapses with initially weak or silent AMPA transmission. A. Single example illustrating the experimental protocol to study the AMPA (À70 mV) and NMDA currents (þ40 mV, slow component) in response to minimal stimulation and the effect of forskolin in a WT slice. Averaged EPSCs (15 responses including failures) from time points indicated are shown on the top. The bar graphs show pooled data on the relative average amplitude (forskolin to baseline) as well as potency and success rate before and after forskolin application for AMPA and NMDA EPSCs, at immature CA3-CA1 synapses (P4-P8) (n ¼ 9). B. Corresponding data for GluA4À/À mice (n ¼ 9). *p < 0.05. GluA4À/À mice (p < 0.001); however, no significant differences in the kinetics of the AMPA EPSCs were detected between the genotypes at any stage of development (P4-P5: WT 4.2 ± 0.6 ms, GluA4À/À 4.6 ± 0.4 ms; P6-P8: WT 5.6 ± 0.7 ms, GluA4À/À 5.7 ± 0.8 ms; P14-P15: WT 10.5 ± 0.8 ms, GluA4À/À 9.6 ± 0.8 ms; P16-P34: WT 9.3 ± 0.9 ms, GluA4À/À 10.2 ± 0.5 ms). This result is consistent with predominant expression of GluA4 'flip' during early development (Monyer et al., 1991) . Additionally, the data suggest that the observed developmental increase in the decay time of AMPA EPSCs depends on mechanisms that operate in the absence of GluA4, such as alternative splicing (Monyer et al., 1991) , heteromerization with GluA2 (Kumar et al., 2002; Ho et al., 2007) or increased dendritic filtering (H€ ausser and Roth, 1997).
To study whether the delayed AMPAfication of synapses in the GluA4À/À mice was reflected in the overall development of glutamatergic input to CA1 neurons, we recorded action potentialindependent spontaneous EPSCs (mEPSCs) from CA1 pyramidal neurons. Previously, no differences in mEPSCs were detected between WT vs. GluA4À/À mice at P4-P5 (Luchkina et al., 2014) . Here we extended this analysis to P10-P11, but again found no significant differences in either frequency or amplitude of mEPSCs between the genotypes in the CA1 pyramidal neurons (WT: 28.5 ± 5.2 events/min, 13.5 ± 0.9 pA (n ¼ 8), GluA4À/À: 34.3 ± 4.9 events/min, 14.1 ± 1.0 pA (n ¼ 12) (Fig. 2C) . Together, these data suggest that glutamatergic input to CA1 pyramidal neurons develops in the absence of GluA4, but the strengthening of AMPAR-mediated transmission relative to NMDAR is developmentally delayed.
3.3. The membrane proximal region of GluA4 CTD is critical for PKA-dependent synaptic potentiation
Having established that the PKA-dependent synaptic insertion of GluA4 is physiologically significant for silent synapse activation and maturation of AMPAR-mediated transmission, we went on to study the molecular mechanism behind this effect. Synaptic trafficking of GluA4 is mainly controlled by interactions mediated by its cytoplasmic tail, as scavenging any endogenous interactions by overexpressing the CTD interferes with its synaptic delivery (Zhu et al., 2000) . Consistently, the effect of forskolin on EPSC amplitude at immature CA1 is strongly and selectively blocked when a GST fusion protein containing the full CTD of GluA4 (GST-A4(835e902)) is included in the intracellular solution (Luchkina et al., 2014) . The GluA4 CTD has previously shown to interact with protein 4.1N (Coleman et al., 2003) , PKCg (Correia et al., 2003) , a-actinin-1 and IQGAP1 (Nuriya et al., 2005) , and it contains PKA/ PKC phosphorylation site at Ser862 (Zhu et al., 2000; Gomes et al., 2007) (Fig. 3A) . In order to delineate in more detail the regions in GluA4 responsible for the blocking effect and to gain insight into the identity of the critical CTD interacting proteins, we used GST-A4 CTD fusion proteins with amino acid deletions or selective point mutations (Fig. 3A) .
Various GST-fusion proteins containing the CTD sequences of the GluA4 were infused into cells at a concentration of 0.5 mM via the patch electrode while monitoring their effects on AMPARemediated evoked EPSCs. Interleaved control experiments with GST ensured that intracellular GST perfusion was not affecting forskolin e induced potentiation of EPSCs (2.64 ± 0.39, n ¼ 11, p < 0.001; not shown). GSTeA4(835e869), containing the membrane proximal region (MPR) of the CTD, fully blocked forskolininduced potentiation of EPSC (1.20 ± 0.15, n ¼ 12, p ¼ 0.35; Fig. 3B ). In contrast, GST-A4(870-902), containing the C-terminal half did not block potentiation (2.40 ± 0.31, n ¼ 6, p < 0.001; Fig. 3B ), suggesting a critical role for the MPR in the synaptic recruitment of GluA4. The MPR contains known interaction sites for protein 4.1N (Coleman et al., 2003) and PKCg (Correia et al., 2003) , both implicated in surface expression of GluA4. To test the role of these proteins in forskolin-induced trafficking of GluA4, we next tested a GSTeA4(835e902;RKR/SSS) fusion protein where Arg841, Lys845 and Arg846, the amino acid residues critical for binding to 4.1N and PKCg, are disrupted (Coleman et al., 2003) . Inclusion of the RKR/SSS mutant to the patch pipette fully blocked the ability of forskolin to enhance EPSC amplitude (1.10 ± 0.23, n ¼ 10, p ¼ 0.76; Fig. 3C ), similarly to the wild-type protein. Thus, suggesting that these interactors alone are not important for the forskolin induced synaptic insertion of GluA4.
Of the remaining protein interactors reported for GluA4 CTD (aactinin-1 and IQGAP1; Nuriya et al., 2005) , the exact sequence requirements are not known. However, it has been reported that phosphorylation of Ser862 strongly inhibits interaction of GluR4 with a-actinin-1 but has little effect on its interaction with IQGAP1 (Nuriya et al., 2005 ). Therefore we also tested GSTeA4 CTD proteins where the serine 862 was mutated to prevent (S862A) or mimic (S862D) phosphorylation. Both GSTeA4(835e902;S862A) and GSTeA4(835e902; S862D) were able to block forskolin-induced potentiation of EPSC to the similar extent as the wild type GST-A4 CTD (1.27 ± 0.23, n ¼ 9, p ¼ 0.3 and 0.99 ± 0.17, n ¼ 7, p ¼ 0.88, respectively; Fig. 3C ). The lack of importance of phosphorylation status suggests that an a-actinin-1 interaction alone cannot explain PKA-dependent synaptic recruitment of GluA4-containing AMPARs at immature hippocampal neurons.
Extreme C-terminal sequences of GluA4 are involved in PKAdependent synaptic potentiation
The other AMPA receptor subunits (GluA1-A3) contain a C-terminal PDZ binding motif critical for their synaptic trafficking (e.g. Hayashi et al., 2000; Malinow and Malenka, 2002; Anggono and Huganir, 2012) . In GluA4, this PDZ binding motif is masked by an extreme C-terminal proline residue, and so far no proteins have been identified to bind this region in vivo (Coleman et al., 2010) . Interestingly, we found that GSTeA4(835e896), where six C-terminal amino acids were deleted, had no effect on forskolin-induced synaptic potentiation in neonatal CA1 (3.10 ± 0.57, n ¼ 6, p < 0.001; Fig. 3D ). Changing the last two amino acids (GST-A4 CTD(835-901;L901A) was sufficient to render the A4 CTD unable to block the potentiation (forskolin induced potentiation 2.25 ± 0.25, n ¼ 7, p < 0.01; Fig. 3D ), while a construct where the only the last proline was removed (GST-A4 CTD(835e901) was still able to inhibit forskolin-induced potentiation (1.22 ± 0.13, n ¼ 7, p > 0.13; Fig. 3D ). These data show that similar to other AMPAR subunits, the C-terminal region of GluA4 has a critical role in its synaptic trafficking. However, as the C-terminal half of GluA4 CTD (GST-A4(870e902)) had no effect on the forskolin induced potentiation on its own (Fig. 3B) , any effects of the extreme C-terminal end on PKA-induced GluA4 trafficking require the membrane proximal region.
Extreme C-terminal sequences regulate synaptic targeting and surface expression of GluA4 in hippocampal neurons
To further understand the molecular mechanisms of GluA4 trafficking, we studied the neuronal distribution of GFP-tagged GluA4 subunits where the CTD amino acids identified as critical for PKA-dependent synaptic plasticity (i.e. the MPR or extreme Cterminal region) were deleted. The GFP-A4(22e902; RKR/SSS) with mutated 4.1N/PKCg interaction site was also included, because of the previous evidence suggesting involvement of this region in GluA4 surface expression (Coleman et al., 2003; Boehm et al., 2006) .
The subcellular distribution of the overexpressed constructs was first evaluated by comparing the GFP signal on confocal images to MAP2 staining that visualizes the full dendritic tree. Both wild type GFP-A4(22e902) and GFP-A4(22e902; RKR/SSS) constructs were strongly expressed along the dendrites. The intensity of GFP-A4(22e896) lacking the extreme C-terminal amino acids was apparently strongest in the soma, although dendritic expression was detectable. In contrast, GFP-A4(22e837; 870e902) lacking the MPR was completely restricted to the cell soma and was not detectable in the cell surface (mean intensity of the surface stain/ mean GFP intensity at the cell soma 0.25 ± 0.08, n ¼ 7, p < 0.01 compared to the wild type GFP-A4(22e902) 0.96 ± 0.10, n ¼ 11; not shown) (Fig. 4A ). As this construct was not transported to dendrites, it could not be used for further analysis of this region in dendritic delivery and synaptic trafficking.
Quantification of the dendritic distribution confirmed no differences in relative dendritic intensity (mean intensity of GFP signal in dendrites/soma) between GFP-A4 and GFP-A4(22-902; RKR/SSS) constructs (Fig. 4B, C) . In contrast, the intensity of GFP-A4(22-896) in the dendrites was significantly lower as compared to the fulllength GFP-A4 (Fig 4B, C) .
Synaptic recruitment of the constructs was evaluated based on their colocalization with PSD95 immunopositive puncta. GFP-A4
and GFP-A4(22-902; RKR/SSS) were clearly detected in the spinelike protrusions and co-localized with PSD95 (Fig. 4B) . Surface staining suggested that the subunits were readily transported to the cell surface, consistent with the findings that spontaneous activity is sufficient for surface delivery of GluA4 (Zhu et al., 2000) . Quantification of synaptic delivery (mean GFP intensity in PSD95 immunopositive regions/mean intensity at the soma) revealed no differences between wild type GFP-A4 and GFP-A4(22-902; RKR/ SSS). Also the relative intensity of synaptic surface expression (GFP surface staining intensity in PSD95 immunopositive regions/PSD95 intensity) was similar for these two constructs (Fig. 4B, C) . In contrast, both synaptic recruitment and relative synaptic surface staining of GFP-A4(22e896) were significantly smaller as compared to the wild type GFP-A4 (Fig. 4B, C) , indicating a role for the extreme C-terminal sequences in synaptic targeting of GluA4. (A4(835-902) ). B. Time course plots showing the effect of forskolin on EPSCs, with various GST-A4 CTD proteins infused to the recorded cell via the patch electrode. Superimposed example traces before and after forskolin application are shown on top and pooled data with denoted statistical significance on the right. GST-A4(870e902) (n ¼ 6), GST-A4(835e869) (n ¼ 12), *p < 0.05. C. Corresponding data for GSTeA4(835e902,S862A) (n ¼ 9), GSTeA4(835e902,S862D) (n ¼ 7) and GSTeA4(835e902,RKR/SSS) (n ¼ 10). D. Corresponding data for GSTeA4(835e896) (n ¼ 6), GSTeA4(835e901, L901A) (n ¼ 7) and GST-A4(835e901) (n ¼ 7).
Discussion
We have previously shown that expression of GluA4 at immature synapses is sufficient to switch the signaling requirements of LTP, by providing a PKA-dependent mechanism to strengthen AMPAR-mediated transmission (Luchkina et al., 2014) . Here, we extend these findings to show that the PKA-driven synaptic insertion of GluA4 depends on unexpected molecular interactions of the extreme C-terminal end of GluA4. Our data further suggest that this mechanism contributes to silent synapse activation at the developing CA3-CA1 circuit to expedite maturation of AMPARmediated transmission. Fig. 4 . The membrane proximal region and extreme C-terminal sequences regulate dendritic delivery, synaptic targeting and surface expression of GluA4 in hippocampal neurons. A. Confocal images of cultured hippocampal neurons expressing full-length GFP-tagged GluA4 (GFP-A4(22e902)), GFP-A4(22e902,RKR/SSS) with disrupted protein 4.1 and PKCg interaction site, GFP-A4(22e896) with deletion of extreme C-terminal region, and GFP-A4(22e837, 870e902) where the membrane proximal region has been deleted. Removal of MPR of the GluA4 CTD leads to accumulation of the construct in neuronal cell body. anti-MAP2 staining (blue), anti-GFP surface staining (red). Scale bar 25 mm. B. Confocal images of cells expressing GFP, GFP-A4(22e902), GFP-A4(22e902,RKR/SSS) and GFP-A4(22e896). The neurons have been surface stained for GFP (red) and, after permeabilization, for PSD95 (blue). Scale bar 25 mm for images of cells, 5 mm for insets of dendrites. C. Pooled data on the dendritic delivery, synaptic recruitment and synaptic surface expression of the various constructs. GFP-A4(22e902) (n ¼ 19), GFP-A4(22e902,RKR/SSS) (n ¼ 12), GFP-A4(22e896) (n ¼ 14) from at least 3 independent neuronal cultures. *p < 0.05.
Physiological significance of GluA4-dependent plasticity in developing glutamatergic circuitry
Silent synapses are a characteristic feature of immature neuronal circuits in various areas of the brain (Kerchner and Nicoll, 2008; Hanse et al., 2013) . Trafficking of AMPA receptors is critical for postsynaptic unsilencing, however, less is known about the relative contribution of various endogenously expressed AMPAR subunits to this process. Using minimal stimulation, we show that PKA-activation induces functional GluA4 AMPA receptors at synapses with initially sub-threshold or silent AMPAR-mediated currents. In WT, but not GluA4 À/À mice, application of forskolin led to a significant increase in the potency and success rate of AMPARmediated EPSCs without significantly affecting NMDAR-mediated EPSCs. The most parsimonious explanation for these results is that PKA activation increases number or conductance of GluA4-containing AMPA receptors at previously undetected release sites. Insertion of homomeric GluA4 receptors with higher single channel conductance (Swanson et al., 1997) to silent and/or labile synapses may also contribute to the observed increase in AMPA potency.
Silent synapse activation is thought to be critical for strengthening of AMPA transmission during development (Kerchner and Nicoll, 2008; Hanse et al., 2013) . In support of a possible role of GluA4-dependent plasticity in silent synapse activation, the relative strength of AMPAR-mediated transmission (AMPA/NMDA ratio) was lower in GluA4À/À mice as compared to WTs during the second and third week of postnatal development (P6-P18), corresponding to the period of intense AMPAfication of transmission at WT CA3-CA1 synapses. However, in line with a previous report (Sagata et al., 2010) no differences in the AMPA/NMDA ratio between the genotypes were detected later on in development, indicating that strengthening of AMPAR-mediated transmission can progress in the absence of GluA4, but with a slower time course.
Intriguingly, during the first days of life (P4-P5), the AMPA/ NMDA ratio was higher in the GluA4À/À mice as compared to WTs. Also, while the success rate of AMPA EPSCs was lower than NMDA EPSCs in WT mice, indicative of postsynaptically silent synapses within the activated synapse population, no corresponding difference was observed in GluA4 À/À mice at this developmental stage (P4-P8). One possible explanation is that GluA4 also contributes to the depression of AMPAR-mediated transmission in response to asynchronous activity at very young synapses (Xiao et al., 2004; Hanse et al., 2009) . Thus, the absence of GluA4 may result in premature stabilization of AMPAR-mediated transmission at certain synapses.
Excitation/inhibition balance at immature networks is heavily regulated via various homeostatic and compensatory mechanisms (e.g. Huupponen et al., 2007) . Also several mechanisms to counterbalance impaired Hebbian plasticity exist (Granger et al., 2013) . From this perspective, it is not surprising that, in the absence of GluA4, no dramatic defects in overall circuit development were detected; no differences in either mEPSC frequency or amplitude were observed in CA1 pyramidal neurons between WT and GluA4À/À mice. Indeed, we previously found that in the absence of GluA4 an adultetype CaMKII-dependent LTP is observed already at P5-P8, suggesting that compensatory mechanisms are recruited to drive development of glutamatergic circuitry in the absence of GluA4. Thus, while not indispensable, the PKA-dependent insertion of GluA4 acts to facilitate the unsilencing and reinforcement of AMPAR-mediated transmission at immature synapses during network development.
Premature, or delayed, unsilencing of AMPAR-silent synapses has been implicated in various neurodevelopmental disorders (Hanse et al., 2013) . Interestingly, GluA4 À/À mice exhibit some aspects of schizophrenia-related phenotypes (Sagata et al., 2010) .
However, whether these phenotypes are due to perturbed glutamatergic development or adult phenotype involving reduced excitatory drive onto parvalbumin-positive fast-spiking interneurons (Fuchs et al., 2007) , remains to be elucidated.
Molecular mechanism underlying PKAedriven synaptic insertion of GluA4
We identified two critical CTD sequences regulating PKAdependent synaptic insertion of GluA4 in immature CA1 pyramidal neurons: the membrane proximal region (MPR) (835-869) and the extreme C-terminal amino acids. The MPR has been previously implicated in GluA4 trafficking (Boehm et al., 2006) and incorporates the established interaction sites for the protein 4.1N (Coleman et al., 2003) , PKCg (Correia et al., 2003) , a-actinin-1 and IQGAP1 (Nuriya et al., 2005) . The MPR sequence has been reported to promote GluA4 surface expression (Carvalho et al., 1999; Coleman et al., 2003; Gomes et al., 2007; Keifer, 2008, 2014) as well as phosphorylation by PKCg at Ser862 (Gomes et al., 2007) . However, using a RKR/SSS mutant to selectively knock out 4.1N and PKCg interactions, we found that these proteins alone are not sufficient for PKA-dependent synaptic delivery of GluA4 at immature CA3-CA1 synapses. This suggests that PKA-and PKCedependent signaling pathways may employ separate molecular mechanisms to regulate GluA4 trafficking and leaves a-actinin-1 and IQGAP as the potential relevant interactors for PKAedependent synaptic insertion.
It has been suggested that a-actinin-1 keeps GluA4 in the intracellular pool and, upon synaptic activity and GluA4 phosphorylation, this binding to a-actinin-1 is disrupted to allow GluA4 incorporation into synapses (Nuriya et al., 2005) . In our experiments the phosphorylation status of Ser862 did not influence the ability of GST-A4 CTD protein to regulate forskolin-induced insertion of GluA4, suggesting that another mechanism independent of the Ser862 phosphorylation is also involved.
Interestingly, and unexpectedly, mutation or deletion of the extreme C-terminal residues of GluA4 completely abolished the ability of GST-A4 CTD to block forskolin-induced potentiation. No functional role for the extreme C-terminal region of GluA4 has yet been proposed. This region is similar to the PDZ binding motif critically involved in GluA1 trafficking but blocked with an extra proline residue Malinow and Malenka, 2002; Coleman et al., 2010) . However, the extreme C-terminal sequence alone was not sufficient to regulate GluA4 trafficking, as GST-A4(870e902) had no effect. To reconcile these findings, we may assume that the C-terminal region, even if it did not directly participate in the mechanisms underlying the forskolin-dependent potentiation, would have a facilitatory influence on the ability of the MPR to interact with the critical protein(s). This influence would be removed by C-terminal mutations explaining the loss of activity, whereas the MPR (the segment 835e869), when expressed in the absence of further C-terminal sequences, would assume an active conformation (Fig. 5) . In the absence of structural data on GluA4 CTD, the physical nature of this influence cannot be established, but based on the activities of wild-type and mutated CTD peptides, it is likely to involve an interaction between the MPR and the C-terminal half of the CTD. We propose a scenario in which the extreme C-terminal residues play an essential role in keeping the Cterminal half of GluA4 CTD in a "closed state", which stabilizes the critical protein interaction(s) of the MPR. C-terminal mutations would prevent the formation of this closed state and the resulting alternative structure would prevent the MPR form adopting a conformation compatible with protein interactions. Such a cooperative role of the C-terminal half is also consistent with the finding that CTD peptide 835-869, lacking the C-terminal half of CTD, inhibits the forskolin-dependent GluA4 insertion like the fulllength CTD peptide.
To further understand the importance of the identified sites for GluA4 trafficking, we studied the distribution of GFP-tagged GluA4 with different CTD mutations in hippocampal cell culture. As reported earlier (Zhu et al., 2000; Coleman et al., 2003 Coleman et al., , 2006 Esteban et al., 2003) , GFP-GluA4 was transported to dendrites and was readily delivered to the surface of hippocampal neurons in culture. Consistent with a critical role of the MPR in trafficking, GFP-GluA4 lacking MPR was completely restricted to the soma, most likely trapped in the endoplasmic reticulum. Both dendritic delivery and synaptic recruitment of GFP-GluA4 with deletion of the extreme Cterminal sequence were significantly diminished as compared to wild type GFP-GluA4, while the RKR/SSS mutant behaved similar to the WT.
Together, these data confirm a critical role for the MPR in trafficking of GluA4 and identify a novel contribution by the extreme Cterminal region to activity dependent synaptic delivery of GluA4. The molecular identity of the proteins interacting with these regions to regulate PKA-dependent trafficking of GluA4 cannot be resolved based on our data. Rather, our data suggest that a yet unidentified interacting protein and/or interactions between the extreme C-terminal region and the MPR regulate PKA-dependent trafficking of GluA4 at immature hippocampal CA3-CA1 synapses.
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